Real-World Observational Study on Vildagliptin With Insulin (VIL-INS) or Vildagliptin and Metformin With Insulin (VIL-MET-INS) Therapy in Indian Patients With Type 2 Diabetes Mellitus

被引:0
作者
Panneerselvam, P. [1 ]
Biswas, Dibakar [2 ]
Singh, Hema [3 ]
Kumar, K. Dilip [4 ]
Kumar, P. Ravi [5 ]
Kalra, Pramila [6 ]
Revankar, Santosh [7 ]
Warrier, Sona [7 ]
机构
[1] Aruna Diabet Ctr, Chennai, India
[2] Dr D Biswas Clin, Diabet & Endocrinol, Kolkata, India
[3] Dr Hemas Clin, Diabet & Endocrinol, Jaipur, India
[4] Careful Diagnost Ctr, Diabet & Endocrinol, Kolkata, India
[5] RK Diabet & Endocrinol Ctr, Diabet & Endocrinol, Ranchi, India
[6] Pramilas Clin, Diabet & Endocrinol, Bengaluru, India
[7] USV Pvt Ltd, Sci Serv, Mumbai, India
关键词
uncontrolled hyperglycemia; oral anti-diabetic agents; vildagliptin and metformin treatment; weight loss; tolerability; hba1c; diabetes; ADD-ON THERAPY; GLYCEMIC CONTROL; EFFICACY; COMBINATION; SAFETY;
D O I
10.7759/cureus.47190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: The therapeutic use of vildagliptin and insulin (VIL-INS) or vildagliptin and metformin in combination with insulin (VIL-MET-INS) in the Indian scenario has yet to be explored by generating real-world evidence. Therefore, the present study aimed to evaluate the demographic, clinical characteristics, and treatment patterns of patients with type 2 diabetes mellitus (T2DM) in Indian settings in the above context.Methodology: This observational study conducted at 600 healthcare centers in India retrospectively analyzed data of adult patients with T2DM who had been treated with either vildagliptin with insulin or a combination of vildagliptin and metformin with insulin. Data were collected from medical records and analyzed by appropriate statistical tests.Results: A total of 12,603 patients with T2DM were included with a mean age of 53.4 years of which 63.8% were males. The majority of patients (n=6511; 51.7%) received a combination of vildagliptin and metformin on top of insulin. A significantly high proportion of patients in the age group of 18-40 years received this treatment compared to patients who were initiated on insulin treatment after vildagliptin and metformin combination (11.6% vs. 9.7%; P<0.001). Of all the patients, 70.0% were able to achieve target glycemic control with either VIS-INS or VIL-MET-INS. After treatment with VIL-INS or VIL-MET-INS, the mean glycated hemoglobin (HbA1c) levels significantly decreased with a mean change of 1.46%. Out of all patients, 13.5% experienced weight changes during treatment, with 67.4% of them showing weight loss. A total of 68 patients reported hypoglycemic events and among them, 49 patients had mild hypoglycemic events. Physician global evaluation of efficacy and tolerability showed a majority of patients rated their experience as good to excellent (86.3% and 86.0%, respectively).Conclusion: Both treatment regimens were effective in terms of reduced HbA1c to achieve glycemic control. Furthermore, it is well tolerated without an increase in the risk of hypoglycemia or weight gain. Hence, this therapy has favorable outcomes for T2DM management in Indian clinical settings.
引用
收藏
页数:15
相关论文
共 50 条
[21]   Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial - a primary care, type 2 diabetes study [J].
Blonde, L. ;
Dagogo-Jack, S. ;
Banerji, M. A. ;
Pratley, R. E. ;
Marcellari, A. ;
Braceras, R. ;
Purkayastha, D. ;
Baron, M. .
DIABETES OBESITY & METABOLISM, 2009, 11 (10) :978-986
[22]   Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision study [J].
Ji, Li-Nong ;
Pan, Chang-Yu ;
Lu, Ju-Ming ;
Li, Hong ;
Li, Qiang ;
Li, Qi-Fu ;
Peng, Yong-De ;
Tian, Hao-Ming ;
Yao, Chen ;
Zhao, Zhi-Gang ;
Zhang, Ru-Ya ;
Wang, Xiang-Ling ;
Wang, Lei .
CARDIOVASCULAR DIABETOLOGY, 2013, 12
[23]   Switching from subcutaneous insulin injection to oral vildagliptin administration in hemodialysis patients with type 2 diabetes: a pilot study [J].
Yoshida, Naoshi ;
Babazono, Tetsuya ;
Hanai, Ko ;
Uchigata, Yasuko .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (08) :1349-1355
[24]   Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review [J].
Davies, M. J. ;
Gagliardino, J. J. ;
Gray, L. J. ;
Khunti, K. ;
Mohan, V. ;
Hughes, R. .
DIABETIC MEDICINE, 2013, 30 (05) :512-524
[25]   Real-world safety of dapagliflozin plus metformin in patients of type 2 diabetes mellitus in China: Post-hoc analysis of the DONATE study [J].
Guo, Lixin ;
Wang, Jing ;
Li, Li ;
Yuan, Lin ;
Chen, Sheng ;
Wang, Hui ;
Li, Tonghuan ;
Qi, Lin ;
Yang, Hong .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 219
[26]   Dapagliflozin Versus Vildagliptin as an Adjuvant to Metformin in Patients With Type 2 Diabetes Mellitus: A Randomized, Open-label Study [J].
Gautam, Kumar ;
Tripathy, Ratikanta ;
Meher, Dayanidhi ;
Sahoo, Jyoti Prakash .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
[27]   Real-world Retrospective Assessment of Initiation and Effectiveness of Dual Combination Therapy with Metformin and Teneligliptin in Drug Naive Indian Type 2 Diabetes Mellitus Patients [J].
Chadha, Manoj ;
Banzal, Subodh ;
Sridhar, S. ;
Goswami, Soumik ;
Barkate, Hanmant ;
Suryawanshi, Sachin ;
Jadhav, Mayur ;
Brid, Manasi .
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (01) :OC16-OC19
[28]   Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes [J].
Levin, Philip ;
Wei, Wenhui ;
Wang, Li ;
Pan, Chunshen ;
Douglas, Damon ;
Baser, Onur .
CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (03) :439-446
[29]   Efficacy of metformin therapy in patients with type 2 diabetes mellitus poorly controlled with insulin therapy [J].
Cortés, MB ;
Arencibia, DM ;
Brier, FL ;
Pino, AO ;
Domínguez, AC ;
Mogollón, EJN .
REVISTA CLINICA ESPANOLA, 2000, 200 (02) :74-76
[30]   Delays in Insulin Initiation among Patients with Type 2 Diabetes Mellitus in Southeast China: A Retrospective, Real-World Study [J].
Chen, Pin ;
Ma, Xiao ;
Chen, Hong ;
Wang, Ke ;
Zhou, Li .
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 :3059-3068